Infectious Disease Therapeutics Market Size, Trends, Analysis, and Outlook By Disease Type (HIV, Hepatitis, Influenza, TB, Malaria, HPV), By End-User (Hospitals, Clinics, Others), by Region, Country, Segment, and Companies, 2024-2030
The global Infectious Disease Therapeutics market size is poised to register 7.86% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Infectious Disease Therapeutics market across By Disease Type (HIV, Hepatitis, Influenza, TB, Malaria, HPV), By End-User (Hospitals, Clinics, Others).
The infectious disease therapeutics market is experiencing significant growth, driven by the increasing prevalence of infectious diseases, emergence of drug-resistant pathogens, and advancements in drug discovery and immunotherapy research. Infectious diseases are caused by pathogenic microorganisms such as bacteria, viruses, fungi, and parasites, posing significant public health challenges and economic burdens worldwide. Treatment options for infectious diseases include antimicrobial drugs, antiviral agents, antifungal medications, and immunomodulatory therapies, which target specific pathogens or host immune responses to control infection and reduce disease severity. With a growing emphasis on pandemic preparedness, antibiotic stewardship, and global health security, pharmaceutical companies, biotechnology firms, and academic research institutions are investing in the development of novel therapeutics, vaccines, and diagnostic tools to combat emerging infectious threats such as COVID-19, Ebola, Zika, and antibiotic-resistant superbugs. Moreover, advancements in genomics, proteomics, and computational biology are driving market expansion, offering new opportunities for target identification, drug repurposing, and personalized medicine approaches in the prevention and treatment of infectious diseases. Additionally, collaborations between industry stakeholders, government agencies, and non-profit organizations are driving innovation in infectious disease therapeutics, fostering the development of new partnerships, funding mechanisms, and regulatory pathways to accelerate the translation of scientific discoveries into clinical interventions and improve patient outcomes in the fight against infectious diseases.
Infectious Disease Therapeutics Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Infectious Disease Therapeutics market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Infectious Disease Therapeutics survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Infectious Disease Therapeutics industry.
Key market trends defining the global Infectious Disease Therapeutics demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Infectious Disease Therapeutics Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Infectious Disease Therapeutics industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Infectious Disease Therapeutics companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Infectious Disease Therapeutics industry
Leading Infectious Disease Therapeutics companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Infectious Disease Therapeutics companies.
Infectious Disease Therapeutics Market Study- Strategic Analysis Review
The Infectious Disease Therapeutics market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Infectious Disease Therapeutics industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Infectious Disease Therapeutics Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Infectious Disease Therapeutics Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Infectious Disease Therapeutics market segments. Similarly, Strong end-user demand is encouraging Canadian Infectious Disease Therapeutics companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Infectious Disease Therapeutics market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Infectious Disease Therapeutics Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Infectious Disease Therapeutics industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Infectious Disease Therapeutics market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Infectious Disease Therapeutics Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Infectious Disease Therapeutics in Asia Pacific. In particular, China, India, and South East Asian Infectious Disease Therapeutics markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Infectious Disease Therapeutics Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Infectious Disease Therapeutics Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Infectious Disease Therapeutics market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Infectious Disease Therapeutics.
Infectious Disease Therapeutics Market Company Profiles
The global Infectious Disease Therapeutics market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are BioCryst Pharmaceuticals Inc, Boehringer Ingelheim GmbH, F. Hoffmann-La Roche Ltd, Gilead, GlaxoSmithKline plc, Janssen Pharmaceutical Inc, Merck & Co. Inc, Novartis AG
Recent Infectious Disease Therapeutics Market Developments
The global Infectious Disease Therapeutics market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Infectious Disease Therapeutics Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Disease Type
HIV
Hepatitis
Influenza
TB
Malaria
HPV
By End-User
Hospitals
Clinics
Others
Geographical Segmentation:
BioCryst Pharmaceuticals Inc
Boehringer Ingelheim GmbH
F. Hoffmann-La Roche Ltd
Gilead
GlaxoSmithKline plc
Janssen Pharmaceutical Inc
Merck & Co. Inc
Novartis AG
Formats Available: Excel, PDF, and PPT
The infectious disease therapeutics market is experiencing significant growth, driven by the increasing prevalence of infectious diseases, emergence of drug-resistant pathogens, and advancements in drug discovery and immunotherapy research. Infectious diseases are caused by pathogenic microorganisms such as bacteria, viruses, fungi, and parasites, posing significant public health challenges and economic burdens worldwide. Treatment options for infectious diseases include antimicrobial drugs, antiviral agents, antifungal medications, and immunomodulatory therapies, which target specific pathogens or host immune responses to control infection and reduce disease severity. With a growing emphasis on pandemic preparedness, antibiotic stewardship, and global health security, pharmaceutical companies, biotechnology firms, and academic research institutions are investing in the development of novel therapeutics, vaccines, and diagnostic tools to combat emerging infectious threats such as COVID-19, Ebola, Zika, and antibiotic-resistant superbugs. Moreover, advancements in genomics, proteomics, and computational biology are driving market expansion, offering new opportunities for target identification, drug repurposing, and personalized medicine approaches in the prevention and treatment of infectious diseases. Additionally, collaborations between industry stakeholders, government agencies, and non-profit organizations are driving innovation in infectious disease therapeutics, fostering the development of new partnerships, funding mechanisms, and regulatory pathways to accelerate the translation of scientific discoveries into clinical interventions and improve patient outcomes in the fight against infectious diseases.
Infectious Disease Therapeutics Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Infectious Disease Therapeutics market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Infectious Disease Therapeutics survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Infectious Disease Therapeutics industry.
Key market trends defining the global Infectious Disease Therapeutics demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Infectious Disease Therapeutics Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Infectious Disease Therapeutics industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Infectious Disease Therapeutics companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Infectious Disease Therapeutics industry
Leading Infectious Disease Therapeutics companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Infectious Disease Therapeutics companies.
Infectious Disease Therapeutics Market Study- Strategic Analysis Review
The Infectious Disease Therapeutics market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Infectious Disease Therapeutics industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Infectious Disease Therapeutics Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Infectious Disease Therapeutics Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Infectious Disease Therapeutics market segments. Similarly, Strong end-user demand is encouraging Canadian Infectious Disease Therapeutics companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Infectious Disease Therapeutics market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Infectious Disease Therapeutics Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Infectious Disease Therapeutics industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Infectious Disease Therapeutics market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Infectious Disease Therapeutics Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Infectious Disease Therapeutics in Asia Pacific. In particular, China, India, and South East Asian Infectious Disease Therapeutics markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Infectious Disease Therapeutics Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Infectious Disease Therapeutics Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Infectious Disease Therapeutics market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Infectious Disease Therapeutics.
Infectious Disease Therapeutics Market Company Profiles
The global Infectious Disease Therapeutics market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are BioCryst Pharmaceuticals Inc, Boehringer Ingelheim GmbH, F. Hoffmann-La Roche Ltd, Gilead, GlaxoSmithKline plc, Janssen Pharmaceutical Inc, Merck & Co. Inc, Novartis AG
Recent Infectious Disease Therapeutics Market Developments
The global Infectious Disease Therapeutics market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Infectious Disease Therapeutics Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Disease Type
HIV
Hepatitis
Influenza
TB
Malaria
HPV
By End-User
Hospitals
Clinics
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
BioCryst Pharmaceuticals Inc
Boehringer Ingelheim GmbH
F. Hoffmann-La Roche Ltd
Gilead
GlaxoSmithKline plc
Janssen Pharmaceutical Inc
Merck & Co. Inc
Novartis AG
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Infectious Disease Therapeutics Market Overview and Key Findings, 2024
1.2 Infectious Disease Therapeutics Market Size and Growth Outlook, 2021- 2030
1.3 Infectious Disease Therapeutics Market Growth Opportunities to 2030
1.4 Key Infectious Disease Therapeutics Market Trends and Challenges
1.4.1 Infectious Disease Therapeutics Market Drivers and Trends
1.4.2 Infectious Disease Therapeutics Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Infectious Disease Therapeutics Companies
2. INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE OUTLOOK TO 2030
2.1 Infectious Disease Therapeutics Market Size Outlook, USD Million, 2021- 2030
2.2 Infectious Disease Therapeutics Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. INFECTIOUS DISEASE THERAPEUTICS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. INFECTIOUS DISEASE THERAPEUTICS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Disease Type
HIV
Hepatitis
Influenza
TB
Malaria
HPV
By End-User
Hospitals
Clinics
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Infectious Disease Therapeutics Market, 2025
5.2 Asia Pacific Infectious Disease Therapeutics Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Infectious Disease Therapeutics Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Infectious Disease Therapeutics Market, 2025
5.5 Europe Infectious Disease Therapeutics Market Size Outlook by Type, 2021- 2030
5.6 Europe Infectious Disease Therapeutics Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Infectious Disease Therapeutics Market, 2025
5.8 North America Infectious Disease Therapeutics Market Size Outlook by Type, 2021- 2030
5.9 North America Infectious Disease Therapeutics Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Infectious Disease Therapeutics Market, 2025
5.11 South America Pacific Infectious Disease Therapeutics Market Size Outlook by Type, 2021- 2030
5.12 South America Infectious Disease Therapeutics Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Infectious Disease Therapeutics Market, 2025
5.14 Middle East Africa Infectious Disease Therapeutics Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Infectious Disease Therapeutics Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Infectious Disease Therapeutics Market Size Outlook and Revenue Growth Forecasts
6.2 US Infectious Disease Therapeutics Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Infectious Disease Therapeutics Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Infectious Disease Therapeutics Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Infectious Disease Therapeutics Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Infectious Disease Therapeutics Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Infectious Disease Therapeutics Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Infectious Disease Therapeutics Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Infectious Disease Therapeutics Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Infectious Disease Therapeutics Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Infectious Disease Therapeutics Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Infectious Disease Therapeutics Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Infectious Disease Therapeutics Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Infectious Disease Therapeutics Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Infectious Disease Therapeutics Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Infectious Disease Therapeutics Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Infectious Disease Therapeutics Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Infectious Disease Therapeutics Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Infectious Disease Therapeutics Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Infectious Disease Therapeutics Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Infectious Disease Therapeutics Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Infectious Disease Therapeutics Industry Drivers and Opportunities
7. INFECTIOUS DISEASE THERAPEUTICS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. INFECTIOUS DISEASE THERAPEUTICS COMPANY PROFILES
8.1 Profiles of Leading Infectious Disease Therapeutics Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
BioCryst Pharmaceuticals Inc
Boehringer Ingelheim GmbH
F. Hoffmann-La Roche Ltd
Gilead
GlaxoSmithKline plc
Janssen Pharmaceutical Inc
Merck & Co. Inc
Novartis AG
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Infectious Disease Therapeutics Market Overview and Key Findings, 2024
1.2 Infectious Disease Therapeutics Market Size and Growth Outlook, 2021- 2030
1.3 Infectious Disease Therapeutics Market Growth Opportunities to 2030
1.4 Key Infectious Disease Therapeutics Market Trends and Challenges
1.4.1 Infectious Disease Therapeutics Market Drivers and Trends
1.4.2 Infectious Disease Therapeutics Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Infectious Disease Therapeutics Companies
2. INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE OUTLOOK TO 2030
2.1 Infectious Disease Therapeutics Market Size Outlook, USD Million, 2021- 2030
2.2 Infectious Disease Therapeutics Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. INFECTIOUS DISEASE THERAPEUTICS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. INFECTIOUS DISEASE THERAPEUTICS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Disease Type
HIV
Hepatitis
Influenza
TB
Malaria
HPV
By End-User
Hospitals
Clinics
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Infectious Disease Therapeutics Market, 2025
5.2 Asia Pacific Infectious Disease Therapeutics Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Infectious Disease Therapeutics Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Infectious Disease Therapeutics Market, 2025
5.5 Europe Infectious Disease Therapeutics Market Size Outlook by Type, 2021- 2030
5.6 Europe Infectious Disease Therapeutics Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Infectious Disease Therapeutics Market, 2025
5.8 North America Infectious Disease Therapeutics Market Size Outlook by Type, 2021- 2030
5.9 North America Infectious Disease Therapeutics Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Infectious Disease Therapeutics Market, 2025
5.11 South America Pacific Infectious Disease Therapeutics Market Size Outlook by Type, 2021- 2030
5.12 South America Infectious Disease Therapeutics Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Infectious Disease Therapeutics Market, 2025
5.14 Middle East Africa Infectious Disease Therapeutics Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Infectious Disease Therapeutics Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Infectious Disease Therapeutics Market Size Outlook and Revenue Growth Forecasts
6.2 US Infectious Disease Therapeutics Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Infectious Disease Therapeutics Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Infectious Disease Therapeutics Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Infectious Disease Therapeutics Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Infectious Disease Therapeutics Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Infectious Disease Therapeutics Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Infectious Disease Therapeutics Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Infectious Disease Therapeutics Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Infectious Disease Therapeutics Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Infectious Disease Therapeutics Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Infectious Disease Therapeutics Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Infectious Disease Therapeutics Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Infectious Disease Therapeutics Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Infectious Disease Therapeutics Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Infectious Disease Therapeutics Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Infectious Disease Therapeutics Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Infectious Disease Therapeutics Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Infectious Disease Therapeutics Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Infectious Disease Therapeutics Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Infectious Disease Therapeutics Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Infectious Disease Therapeutics Industry Drivers and Opportunities
7. INFECTIOUS DISEASE THERAPEUTICS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. INFECTIOUS DISEASE THERAPEUTICS COMPANY PROFILES
8.1 Profiles of Leading Infectious Disease Therapeutics Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
BioCryst Pharmaceuticals Inc
Boehringer Ingelheim GmbH
F. Hoffmann-La Roche Ltd
Gilead
GlaxoSmithKline plc
Janssen Pharmaceutical Inc
Merck & Co. Inc
Novartis AG
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
